Company
Sydney, NSW
Every investor coverage indicates participated in a round Brain and Mind Centre raised.
Companies Brain and Mind Centre acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Samuel Banister | Team Leader in Medicinal Chemistry (former) | Startup Daily |
Stories naming Brain and Mind Centre. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.